Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Change in HbA1c With Biphasic Insulin Aspart 70/30 in Two Different Treatment Regiments in Subjects With Type 2 Diabetes Inadequately Controlled With Oral Anti-diabetic Drug Therapy.

NCT00184561 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00184561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00184561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Change in HbA1c With Biphasic Insulin Aspart 70/30 in Two Different Treatment Regiments in Subjects With Type 2 Diabetes Inadequately Controlled With Oral Anti-diabetic Drug Therapy.
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2005
Completion date
July 31, 2006
Enrollment
321 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2